Indivior Pharmaceuticals, Inc. INDV
36.28 USD +0.91 (+2.57%)
At closeNov 2, 2026, 4:00 PM EST
36.30 +0.02 +0.06%
After hours · Nov 2, 4:00 PM ET
35.32 Day range 37.01
26.74 52-week range 42.81
- YTD
- 0.00%
- 1 year
- 0.00%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.24B | 1.19B | 1.09B | 901.00M | 791.00M | |
| 993.00M | 957.00M | 919.00M | 750.00M | 664.00M | |
| 262.00M | 38.00M | -154.00M | -81.00M | 213.00M | |
| 210.00M | 7.00M | -126.00M | -44.00M | 205.00M | |
| 1.64 | 0.05 | -0.92 | -0.32 | 1.35 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 195.00M | 319.00M | 316.00M | 774.00M | 1.10B | |
| 1.20B | 1.32B | 1.76B | 1.77B | 1.83B | |
| 1.30B | 1.65B | 1.95B | 1.72B | 1.63B | |
| 351.00M | 375.00M | 283.00M | 277.00M | 286.00M | |
| -98.00M | -337.00M | -191.00M | 51.00M | 203.00M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -27.00M | 36.00M | -300.00M | -4.00M | 395.00M | |
| -66.00M | 69.00M | -95.00M | -222.00M | -14.00M | |
| -30.00M | -102.00M | -64.00M | -101.00M | -94.00M | |
| -66.00M | -29.00M | -8.00M | -5.00M | -14.00M | |
| -124.00M | 3.00M | -459.00M | -327.00M | 244.00M |